Concepedia

Publication | Open Access

Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study

DOIFull Paper Access

34

Citations

22

References

2023

Year

Lucy Finnigan, Mark Philip Cassar, Margaret James Koziel, Joël Pradines, Hanan Lamlum, Karim Azer, Dan Kirby, Hugh Montgomery, Stefan Neubauer, Ladislav Valkovič,
EClinicalMedicine

Abstract

Axcella Therapeutics.

References

YearCitations

Page 1